A rock in the toll road: IRAK4 inhibition of TLR4-MyD88 signaling as potential treatment for addiction

Brain Behav Immun. 2022 Aug:104:74-75. doi: 10.1016/j.bbi.2022.05.013. Epub 2022 May 23.

Authors

Andrew D Gaulden¹, Jayme R McReynolds²

Affiliations

¹ Department of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
² Department of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States. Electronic address: jayme.mcreynolds@uc.edu.

PMID: 35618228
DOI: 10.1016/j.bbi.2022.05.013

No abstract available

Publication types

Editorial

MeSH terms

Adaptor Proteins, Signal Transducing
Interleukin-1 Receptor-Associated Kinases* / metabolism
Myeloid Differentiation Factor 88 / metabolism
NF-kappa B / metabolism
Signal Transduction
Toll-Like Receptor 4* / metabolism

Substances

Interleukin-1 Receptor-Associated Kinases
Toll-Like Receptor 4
Myeloid Differentiation Factor 88
NF-kappa B
Adaptor Proteins, Signal Transducing